Pembrolizumab and epacadostat for NSCLC: ECHO-306/KEYNOTE-715
The European Lung Cancer Congress (ELCC) 2018, in Geneva, Switzerland, presented an array of exciting lung cancer trial updates. Speaking from the meeting, Marina Garassino, MD, of the Istituto Nazion...
Author: VJOncology
Added: 04/20/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Politics | Switzerland Health